VIICTR
Profiles
ORIT
Pediatrics RRO
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
HEIMBERGER, AMY B
One or more keywords matched the following items that are connected to
HEIMBERGER, AMY B
Item Type
Name
Academic Article
The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.
Academic Article
EGFRvIII-targeted vaccination therapy of malignant glioma.
Academic Article
Clinical applications of a peptide-based vaccine for glioblastoma.
Academic Article
Glioma-associated cancer-initiating cells induce immunosuppression.
Academic Article
The natural history of EGFR and EGFRvIII in glioblastoma patients.
Academic Article
Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Academic Article
Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.
Academic Article
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
Academic Article
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Academic Article
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
Academic Article
Topotecan enhances immune clearance of gliomas.
Academic Article
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
Academic Article
Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.
Academic Article
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Academic Article
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway.
Academic Article
Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?
Academic Article
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.
Academic Article
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
Academic Article
Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
Academic Article
Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma.
Academic Article
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
Academic Article
Hypoxia potentiates glioma-mediated immunosuppression.
Academic Article
Consensus on the role of human cytomegalovirus in glioblastoma.
Concept
Glioblastoma
Academic Article
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.
Academic Article
Mesenchymal differentiation mediated by NF-?B promotes radiation resistance in glioblastoma.
Academic Article
Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.
Academic Article
Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.
Academic Article
Immunotherapy for primary brain tumors: no longer a matter of privilege.
Academic Article
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
Academic Article
FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.
Academic Article
The role of STAT3 in tumor-mediated immune suppression.
Academic Article
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
Academic Article
Immunosuppressive mechanisms in glioblastoma.
Academic Article
Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.
Academic Article
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.
Academic Article
Serum microRNA profiling in patients with glioblastoma: a survival analysis.
Academic Article
PD-L1 expression and prognostic impact in glioblastoma
Academic Article
Cytomegalovirus-targeted immunotherapy and glioblastoma
Academic Article
The natural history of EGFR and EGFRvIII in glioblastoma patients
Academic Article
Prioritization schema for immunotherapy clinical trials in glioblastoma
Academic Article
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma
Academic Article
Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.
Academic Article
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
Academic Article
Identification of metabolites in plasma for predicting survival in glioblastoma.
Academic Article
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.
Academic Article
The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.
Academic Article
PD-L1 expression and prognostic impact in glioblastoma.
Academic Article
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Academic Article
Immunotherapy in glioblastoma: emerging options in precision medicine.
Academic Article
GBM-associated mutations and altered protein expression are more common in young patients.
Academic Article
Prioritization schema for immunotherapy clinical trials in glioblastoma.
Academic Article
Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.
Academic Article
Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.
Academic Article
Tumor Vaccines for Malignant Gliomas.
Academic Article
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
Academic Article
Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.
Academic Article
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
Academic Article
Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma".
Academic Article
Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
Academic Article
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target.
Academic Article
Targetable Gene Fusions Associate With the IDH Wild-Type Astrocytic Lineage in Adult Gliomas.
Academic Article
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation.
Academic Article
Perilesional Resection of Glioblastoma Is Independently Associated With Improved Outcomes.
Academic Article
Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.
Academic Article
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.
Academic Article
Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
Academic Article
Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?
Academic Article
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Academic Article
Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
Academic Article
Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment.
Academic Article
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Academic Article
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
Academic Article
MiR-181 Family Modulates Osteopontin in Glioblastoma Multiforme.
Academic Article
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
Academic Article
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.
Academic Article
The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma.
Academic Article
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme.
Academic Article
A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma.
Academic Article
Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms.
Academic Article
Targeting the av integrin/TGF-? axis improves natural killer cell function against glioblastoma stem cells.
Academic Article
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling.
Academic Article
Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma.
Academic Article
Immune Modulatory Short Noncoding RNAs Targeting the Glioblastoma Microenvironment.
Academic Article
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma.
Academic Article
New Approaches to Glioblastoma.
Academic Article
The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
Academic Article
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article
Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Academic Article
Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression.
Academic Article
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
Academic Article
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
Academic Article
A Window of Opportunity to Overcome Therapeutic Failure in Neuro-Oncology.
Academic Article
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
Academic Article
Immune landscape of a genetically engineered murine model of glioma compared with human glioma.
Academic Article
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
Academic Article
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment.
Academic Article
Next Steps for Immunotherapy in Glioblastoma.
Academic Article
CXCR4 expression is associated with proneural-to-mesenchymal transition in glioblastoma.
Academic Article
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease.
Academic Article
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy.
Academic Article
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells.
Academic Article
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.
Academic Article
Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma.
Academic Article
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma.
Academic Article
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma.
Academic Article
Multimodal neuro-nanotechnology: Challenging the existing paradigm in glioblastoma therapy.
Search Criteria
Glioblastoma